Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective-Reference-Cited by-同舟云学术

Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective

Published:2021-12 Issue: Volume: Page:
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Veilleux Olivier^ORCID,Claveau Jean-Sébastien,Alaoui Habiba,Roy Jean,Ahmad Imran,Delisle Jean-Sébastien,Kiss Thomas,Bambace Nadia M.,Bernard Léa,Cohen Sandra,Sauvageau Guy,Fleury Isabelle,Mollica Luigina,Roy Denis-Claude,Serroukh Yasmina,Lachance Sylvie

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference49 articles.

1. Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496);Gordon;J Clin Oncol,2013

2. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial;Duggan;J Clin Oncol,2003

3. Adapted treatment guided by interim PET-CT scan in advanced Hodgkin's lymphoma;Johnson;N Engl J Med,2016

4. US Intergroup trial of response-adapted therapy for stage III to IV Hodgkin lymphoma using early interim fluorodeoxyglucose-positron emission tomography imaging: Southwest Oncology Group S0816;Press;J Clin Oncol,2016

5. Treatment-resistant Hodgkin lymphoma: defining the role of autologous transplantation;Blum;Cancer J,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary;Annals of Hematology;2023-07-10

2. Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma;Journal of Clinical Medicine;2022-11-06

3. Treatment pathways and clinical outcomes in Hodgkin lymphoma outside Europe and North America: results from the international, multicenter, retrospective, B-HOLISTIC study;Leukemia & Lymphoma;2022-10-06